NCT04155307

Brief Summary

Terminal constipation affects 13 to 20% of the french population. Anismus is defined by an absence of relaxation or a paradoxical contraction of the striated anal sphincter muscle during defecation. Anismus is one of the main causes of terminal constipation. Anismus diagnosis is retained if 2 out of 3 examinations (manometry, electromyogram, defecography) are positive. EndoFLIP® is a new medical device developed to measure distensibility of a hollow organ. Anal EndoFLIP® l could be a more sensitive and specific tool for detecting anismus in patients with distal constipation. 60 patients suffering from distal constipation will be included in order to perform, in addition to the usual examinations, an anal EndoFlip in order to test the sensitivity and specificity of this method for the diagnosis of anismus.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 5, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 7, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

January 14, 2020

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 21, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 21, 2024

Completed
Last Updated

September 11, 2025

Status Verified

September 1, 2025

Enrollment Period

4.4 years

First QC Date

November 5, 2019

Last Update Submit

September 10, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Sensitivity of the anal distensibility evaluated with the EndoFLIP® technique for the diagnosis of anismus

    30 min

  • Specificity of the anal distensibility evaluated with the EndoFLIP® technique for the diagnosis of anismus

    30 min

Study Arms (1)

Detection of anismus in patients with distal constipation

EXPERIMENTAL
Device: Anal EndoFLIP®Diagnostic Test: Anal ManometryDiagnostic Test: DefecographyDiagnostic Test: Electromyogram

Interventions

Anal EndoFLIP® measure to evaluate anal compliance

Detection of anismus in patients with distal constipation
Anal ManometryDIAGNOSTIC_TEST

Anal Manometry done in standard care

Detection of anismus in patients with distal constipation
DefecographyDIAGNOSTIC_TEST

Defecographydone in standard care

Detection of anismus in patients with distal constipation
ElectromyogramDIAGNOSTIC_TEST

Electromyogram done in standard care

Detection of anismus in patients with distal constipation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patient older than 18 years
  • patient with distal constipation defined according to the Rome IV criteria, for at least 3 months and verified by a transit time study showing a predominant slowing of markers at the recto-sigmoid level.
  • patient who read and signed the informed consent form

You may not qualify if:

  • Patients with a predominant right of left colonic constipation;
  • Pregnant woman or woman with no effective contraception and of childbearing age
  • Patient with inflammatory bowel disease, ischemic colitis, history of colon or rectal cancer, infectious colitis or proctologic disease.
  • Patient with anorectal malformation
  • Patient with an history of pelvic floor radiotherapy
  • Patient with a digestive stoma
  • Insertion of the probe impossible or painful
  • Patient not understanding or reading French
  • Patients under guardianship, curatorship, safeguard of justice
  • Patient without liberty by administrative or judicial decision

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rouen University Hospital

Rouen, France

Location

MeSH Terms

Interventions

DefecographyElectromyography

Intervention Hierarchy (Ancestors)

Radiography, AbdominalRadiographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosisMyography

Study Officials

  • Laura BRIL, MD

    University Hospital, Rouen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 5, 2019

First Posted

November 7, 2019

Study Start

January 14, 2020

Primary Completion

May 21, 2024

Study Completion

May 21, 2024

Last Updated

September 11, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations